OpenLink Software

About: The report that NIPRD has developed Niprimune for the treatment of  COVID-19 is MISLEADING as the drug -Niprimune- is yet to conclude clinical trials to test it efficacy as a treatment for COVID-19. As it stands, Niprmune is an immune booster and not a cure or treatment for COVID-19.     Permalink

an Entity references as follows:

Subject of Sentences In Document
Object of Sentences In Document
Explicit Coreferences
Implicit Coreferences
Graph IRICount
http://data.cimple.eu/graph/claimreview5 triples
Faceted Search & Find service v1.16.115

Alternative Linked Data Documents: ODE     Raw Data in: CXML | CSV | RDF ( N-Triples N3/Turtle JSON XML ) | OData ( Atom JSON ) | Microdata ( JSON HTML) | JSON-LD    About   
This material is Open Knowledge   W3C Semantic Web Technology [RDF Data] This material is Open Knowledge Creative Commons License Valid XHTML + RDFa
This work is licensed under a Creative Commons Attribution-Share Alike 3.0 Unported License.
OpenLink Virtuoso version 07.20.3238 as of Jul 16 2024, on Linux (x86_64-pc-linux-musl), Single-Server Edition (126 GB total memory, 6 GB memory in use)
Copyright © 2009-2025 OpenLink Software